Steris (STE) risk factors: FY2026 10-K

1. Changes in economic climate may adversely affect us.
2. The effects of geopolitical instability may adversely affect us and create significant risks and uncertainties for our business, with the ultimate impact dependent on future developments, which are highly uncertain and unpredictable.
3. Compliance with multiple, and potentially conflicting, international laws and regulations, import and export limitations, anti-corruption laws, and exchange controls may be difficult, burdensome or expensive.

Read these in Item 1A · See the changes

1. Changes in healthcare policy or government and other third-party payor reimbursement levels to healthcare providers, or failure to meet healthcare reimbursement or other requirements, might negatively impact our business.
2. Product and Service Related Regulations and Claims
3. We are subject to extensive regulatory requirements and must receive and maintain regulatory clearance or approval for many products and operations. Failure to receive or maintain, or delays in receiving, clearance or approvals may negatively impact our revenues, profitability, financial condition, or value.
4. Our products are subject to recalls and restrictions, even after receiving U.S. or foreign regulatory clearance or approval.
5. Our business and financial condition could be adversely affected by difficulties in acquiring or maintaining a proprietary intellectual ownership position.
6. We may be adversely impacted by changes in tax laws or challenges to our tax positions, and our effective tax rate is uncertain and may vary from expectations, which could have a material impact on our results of operations and earnings per share.reworded
7. Current economic and political conditions make tax rules in any jurisdiction subject to significant change.
8. Changes in tax treaties and trade agreements could negatively impact our costs, results of operations and earnings per share.
9. Legislation relating to the denial of U.S. federal or state governmental contracts to U.S. companies that redomicile abroad could adversely affect our business.

Read these in Item 1A · See the changes

1. Supply chain disruption might increase our production costs, limit our production capabilities or curtail our operations.
2. Our operations, and those of our suppliers, are subject to a variety of business continuity hazards and risks, any of which could interrupt production or operations or otherwise adversely affect our performance, results, or value.
3. Expectations relating to corporate responsibility considerations expose us to potential liabilities, increased costs, reputational harm and other adverse effects on our business.
4. We may be adversely affected by global climate change or by existing and future legal, regulatory or market responses to such change.
5. Our operations are subject to regulations and permitting, which may be changed or amended by the relevant authorities, and which may limit or eliminate our current operations or increase the complexity, burden, or expense of compliance, and regulated materials or processes that we use in our operations are, and may in the future become subject to litigation.reworded
6. A pandemic or similar public health crisis could have a material adverse impact on our ability to staff our operations.
7. Our business and results of operations may be adversely affected if we are unable to recruit and retain qualified management and other personnel.
8. We could experience a failure of a key information technology system, process or site or a breach of information security, including a cybersecurity breach of one or more key information technology systems, networks, processes, associated sites or service providers; failure to manage these and other risks associated with the use of sophisticated technology could materially impact our business.rewordedCybersecurity
9. Our debt level or access to credit markets may limit our financial and business flexibility.

Read these in Item 1A · See the changes

1. We engage in acquisitions and affiliations, divestitures, and other business arrangements. Our growth may be adversely affected if we are unable to successfully identify and price strategic business candidates or otherwise optimize our business portfolio.reworded
2. Our investments in our business and product offerings may not be as successful as anticipated.new
3. Our business realignment initiatives may not be as successful as anticipated.
4. The integration of acquired businesses into STERIS or working arrangements with joint venture partners may not be as successful as anticipated.reworded
5. Past and future business acquisitions may not be as accretive to STERIS’s earnings per share and cash flow from operations per share, which may negatively affect the market price of STERIS shares.
6. STERIS has incurred and expects to incur significant transaction and related costs in connection with strategic transactions, which may be in excess of those anticipated.reworded
7. We have recorded goodwill and other intangible assets that could become impaired and result in material non-cash charges to our results of operation in the future.

Read these in Item 1A · See the changes

Headings in the FY2025 10-K with no match this year.

1. We might be adversely impacted by tax legislation or challenges to our tax positions.
2. The U.S. Internal Revenue Service (the “IRS”) may not agree that we are a non-U.S. corporation for U.S. federal tax purposes.
3. We may fail to realize all of the anticipated benefits of our strategic business initiatives, as well as acquisitions, dispositions or joint ventures, or those benefits may take longer to realize than expected.